Skip to main content
Journal cover image

Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).

Publication ,  Journal Article
Brennan, JM; Sketch, MH; Dai, D; Trilesskaya, M; Al-Hejily, W; Rao, SV; Brilakis, E; Messenger, JC; Shaw, RE; Anstrom, KJ; Peterson, ED; Douglas, PS
Published in: Catheter Cardiovasc Interv
January 1, 2016

OBJECTIVES: To evaluate the safety of drug-eluting stents (DES) when treating patients with failing saphenous vein grafts (SVG). BACKGROUND: DES reduce target vessel revascularization in patients with failing SVGs; however, compared with bare metal stents (BMS), DES have been variably associated with increased mortality. METHODS: Clinical records from National Cardiovascular Data Registry(®) CathPCI Registry(®) (49,325 older individuals [≥65 years] who underwent SVG stenting 2005-2009) were linked to Medicare claims to create a longitudinal record. Death, myocardial infarction (MI), and urgent revascularization with DES versus BMS were evaluated to 3 years using propensity matching (PM). Results were stratified by clinical presentation (acute coronary syndrome [ACS], non-ACS), previous lesion treatment (in-stent, de novo), and graft segment (aortic, body, distal anastomosis). RESULTS: In this older cohort (median age, 75 years), acute presentations were prevalent (ACS, 69%; TIMI flow <3, 45%), and adverse clinical outcomes were common by 3 years (death, 24.5%; MI, 14.6%; urgent revascularization, 29.5%). Among DES patients (n = 31,403), 3-year mortality was lower (vs. BMS) (22.7% vs. 28.0%, P < 0.001; PM hazard ratio [HR] 0.87, 95% confidence interval 0.83-0.91), and no difference was observed in the adjusted risk for MI (PM HR 0.97, 0.91 to 1.03) or urgent revascularization (PM HR 1.04, 0.99-1.08). These findings were independent of clinical presentation, previous lesion treatment, and graft segment (P interaction, ns). CONCLUSIONS: In this large SVG PCI cohort, all-cause mortality was lower among those receiving DES, and no difference in MI or urgent revascularization was observed to 3 years. © 2015 Wiley Periodicals, Inc.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Catheter Cardiovasc Interv

DOI

EISSN

1522-726X

Publication Date

January 1, 2016

Volume

87

Issue

1

Start / End Page

43 / 49

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Saphenous Vein
  • Retrospective Studies
  • Registries
  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Medicare
  • Male
  • Incidence
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brennan, J. M., Sketch, M. H., Dai, D., Trilesskaya, M., Al-Hejily, W., Rao, S. V., … Douglas, P. S. (2016). Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009). Catheter Cardiovasc Interv, 87(1), 43–49. https://doi.org/10.1002/ccd.25979
Brennan, J Matthew, Michael H. Sketch, David Dai, Marina Trilesskaya, Wesam Al-Hejily, Sunil V. Rao, Emmanouil Brilakis, et al. “Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).Catheter Cardiovasc Interv 87, no. 1 (January 1, 2016): 43–49. https://doi.org/10.1002/ccd.25979.
Brennan JM, Sketch MH, Dai D, Trilesskaya M, Al-Hejily W, Rao SV, Brilakis E, Messenger JC, Shaw RE, Anstrom KJ, Peterson ED, Douglas PS. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009). Catheter Cardiovasc Interv. 2016 Jan 1;87(1):43–49.
Journal cover image

Published In

Catheter Cardiovasc Interv

DOI

EISSN

1522-726X

Publication Date

January 1, 2016

Volume

87

Issue

1

Start / End Page

43 / 49

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Saphenous Vein
  • Retrospective Studies
  • Registries
  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Medicare
  • Male
  • Incidence